Redoxis AB
556726-4451ActiveSwedish CRO specializing in preclinical autoimmune and inflammatory disease models.
Contract Research Organization (CRO)redoxis.com
Oversigt
- 19
- Medarbejdere
- 28.6mio SEK
- Omsætning
- 2007
- Grundlagt
Nøglebeslutningstagere
Malin Hultqvist
Chief Executive Officer
@redoxis.com+46707XXXXXX
Nina Woodworth
Chief Operating Officer
@redoxis.com+46760XXXXXX
Caroline Alkner
Head of In Vitro
@redoxis.com
Polyxeni Mantani
Director of Immunology
@redoxis.com
+17 flere kontakter i Funnelfeedr
Beskrivelse
Redoxis is a specialized Swedish Contract Research Organization (CRO) founded in 2007. Their core expertise lies in preclinical drug development and the efficacy evaluation of novel therapies targeting inflammatory and autoimmune diseases. They offer a comprehensive portfolio of services, including...